Last Updated: November 6, 2026

Details for Patent: 10,812,238


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,812,238
Title:Configurable reference signals
Abstract:It is recognized herein that current LTE reference signals may be inadequate for future cellular (e.g., New Radio) systems. Configurable reference signals are described herein. The configurable reference signals can support mixed numerologies and different reference signal (RS) functions. Further, reference signals can be configured so as to support beam sweeping and beamforming training.
Inventor(s):Qian Zhang, Qing Li, Allan Y. Tsai, Guodong Zhang, Lakshmi R. Iyer, Tianyi Xu, Pascal M. Adjakple, Ahmed ElSamadouny, Salman Khan, Yifan Li
Assignee: InterDigital Patent Holdings Inc
Application Number:US16/093,287
Patent Claim Types:
see list of patent claims
Use; Composition; Device;

Drugs Protected by US Patent 10,812,238

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.